News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

German Database Study Hints Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Diabetes Drug Cuts Alzheimer's Risk



7/14/2014 7:29:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer's disease, although conclusive proof from a more formal trial could be about five years away.

Earlier studies have suggested that people and animals given the widely used pill for type-2 diabetes, called pioglitazone, were less likely to develop Alzheimer's or other forms of dementia. The medicine is sold under the brand name Actos by Japanese drugmaker Takeda Pharmaceutical Co Ltd.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Fox News


comments powered by Disqus
Reuters
Fox News
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES